rs1131691616
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018684.4(ZC4H2):c.199C>T(p.Arg67*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 22)
Consequence
ZC4H2
NM_018684.4 stop_gained
NM_018684.4 stop_gained
Scores
2
2
1
Clinical Significance
Conservation
PhyloP100: 3.87
Genes affected
ZC4H2 (HGNC:24931): (zinc finger C4H2-type containing) This gene encodes a member of the zinc finger domain-containing protein family. This family member has a C-terminal zinc finger domain that is characterized by four cysteine residues and two histidine residues, and it also includes a coiled-coil region. This protein has been detected as an autoantigen in hepatocellular carcinoma patients. This gene has been identified as a potential candidate for X-linked cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-64921843-G-A is Pathogenic according to our data. Variant chrX-64921843-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 429826.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-64921843-G-A is described in Lovd as [Pathogenic]. Variant chrX-64921843-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZC4H2 | NM_018684.4 | c.199C>T | p.Arg67* | stop_gained | 2/5 | ENST00000374839.8 | NP_061154.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZC4H2 | ENST00000374839.8 | c.199C>T | p.Arg67* | stop_gained | 2/5 | 1 | NM_018684.4 | ENSP00000363972.3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Wieacker-Wolff syndrome, female-restricted Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Lifecell International Pvt. Ltd | - | A Heterozygous Nonsense variant c.199C>T in Exon 2 of the ZC4H2 gene that results in the amino acid substitution p.Arg67* was identified. The observed variant is novel in gnomAD exomes and genomes. The severity of the impact of this variant on the protein is high, based on the effect of the protein and REVEL score. Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic/ Likely Pathogenic [Variation ID:429826]. The observed variant has been previously reported in patients affected with arthrogryposis multiplex congenita (Frints, Suzanna G M et al., 2019). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 24, 2023 | The heterozygous p.Arg67Ter variant in ZC4H2 was identified by our study in one individual with female-restricted Wieacker-Wolff syndrome. Trio exome analysis showed this variant to be de novo. The p.Arg67Ter variant in ZC4H2 has been previously reported in two individuals with Wieacker-Wolff syndrome (PMID: 31206972; PMID: 31885220). This variant was found to be de novo in two individuals with confirmed paternity and maternity (PMID: 31206972; PMID: 31885220). This variant was absent from large population studies. This variant has also been reported in ClinVar (Variation ID: 429826) and has been interpreted as pathogenic by GeneDx, Fulgent Genetics, and Ambry Genetics and as likely pathogenic by Center for Pediatric Genomic Medicine,Children's Mercy Hospital and Clinics and Mendelics. In vitro functional studies provide some evidence that the p.Arg67Ter variant may impact protein function (PMID: 31885220). However, these types of assays may not accurately represent biological function. This nonsense variant leads to a premature termination codon at position 67, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the ZC4H2 gene is an established disease mechanism in female-restricted Wieacker-Wolff syndrome. In summary, this variant meets criteria to be classified as pathogenic for female-restricted Wieacker-Wolff syndrome. ACMG/AMP Criteria applied: PVS1, PS2, PS3_Supporting, PS4_Supporting, PM2_Supporting (Richards 2015). - |
Wieacker-Wolff syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
not provided Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Apr 13, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 12, 2023 | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Published functional studies demonstrate a damaging effect: a truncated protein with altered subcellular localization (Wang et al., 2020); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31349857, 31885220, 33949289, 36250278, 31206972) - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 06, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
FATHMM_MKL
Uncertain
D
Vest4
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at